Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Dietary Supplement ARTNEO in Patients With Knee Osteoarthritis
NCT06032442Completed
- Sponsor
- Petrovax Pharm
- Start
- Mar 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in osteoarthritis (OA) (2 arms), sponsored by Petrovax Pharm. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Total Score at 6 months. Started Mar 2022; status: completed.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06032442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06032442.